Loading clinical trials...
Loading clinical trials...
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Indiana University
NCT06616857 · Cystic Fibrosis (CF)
NCT07148739 · Cystic Fibrosis (CF)
NCT07491653 · Prediabetes
NCT07525622 · Prediabetes
NCT07192679 · Cystic Fibrosis (CF)
Indiana University Health, University Hospital
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions